Developing and Assessing an Implantable Insulin Infusion Pump: Interactions of University, Industry, and Government
- 1 July 1986
- journal article
- Published by Cambridge University Press (CUP) in International Journal of Technology Assessment in Health Care
- Vol. 2 (3) , 471-482
- https://doi.org/10.1017/s0266462300002579
Abstract
The validity of technology assessment may depend largely upon who performs the job, and when they get involved. The options are many. Industry may hire a small private laboratory to perform animal trials on a completed device or drug; manufacturers may support their own in-house laboratories or even study beds; industry may contract with hospitals or private medical groups to evaluate a potential product. It is the thesis of this discussion that there is a different option which brings together the strengths of three often stubbornly independent institutions: industry, university-based investigators, and federal science granting agencies.Keywords
This publication has 5 references indexed in Scilit:
- Biohybrid artificial pancreas. Long-term insulin secretion by devices seeded with canine isletsDiabetes, 1985
- Successful long-term survival of pancreatic islet allografts in spontaneous or pancreatectomy-induced diabetes in dogs. Cyclosporine-induced immune unresponsivenessDiabetes, 1985
- Acute complications associated with insulin infusion pump therapy. Report of experience with 161 patientsJAMA, 1984
- Glycosylated insulin complexed to Concanavalin A. Biochemical basis for a closed-loop insulin delivery systemDiabetes, 1983
- The use, in diabetic rats and monkeys, of artificial capillary units containing cultured islets of Langerhans (artificial endocrine pancreas)Diabetes, 1977